105 related articles for article (PubMed ID: 37717980)
1. RNF152 Suppresses Fatty Acid Oxidation and Metastasis of Lung Adenocarcinoma by Inhibiting IRAK1-Mediated AKR1B10 Expression.
Zhu D; Nie Y; Zhao Y; Chen X; Yang Z; Yang Y
Am J Pathol; 2023 Oct; 193(10):1603-1617. PubMed ID: 37717980
[TBL] [Abstract][Full Text] [Related]
2. IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma.
Cheng BY; Lau EY; Leung HW; Leung CO; Ho NP; Gurung S; Cheng LK; Lin CH; Lo RC; Ma S; Ng IO; Lee TK
Cancer Res; 2018 May; 78(9):2332-2342. PubMed ID: 29483095
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA linc00665 promotes lung adenocarcinoma progression and functions as ceRNA to regulate AKR1B10-ERK signaling by sponging miR-98.
Cong Z; Diao Y; Xu Y; Li X; Jiang Z; Shao C; Ji S; Shen Y; De W; Qiang Y
Cell Death Dis; 2019 Jan; 10(2):84. PubMed ID: 30692511
[TBL] [Abstract][Full Text] [Related]
4. RNF182 induces p65 ubiquitination to affect PDL1 transcription and suppress immune evasion in lung adenocarcinoma.
Zeng X; Tang X; Chen X; Wen H
Immun Inflamm Dis; 2023 May; 11(5):e864. PubMed ID: 37249301
[TBL] [Abstract][Full Text] [Related]
5. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
6. SMARCA4 oncogenic potential via IRAK1 enhancer to activate Gankyrin and AKR1B10 in liver cancer.
Kim SY; Shen Q; Son K; Kim HS; Yang HD; Na MJ; Shin E; Yu S; Kang K; You JS; Yu KR; Jeong SM; Lee EK; Ahn YM; Park WS; Nam SW
Oncogene; 2021 Jul; 40(28):4652-4662. PubMed ID: 34140644
[TBL] [Abstract][Full Text] [Related]
7. Homeobox A5 activates p53 pathway to inhibit proliferation and promote apoptosis of adrenocortical carcinoma cells by inducing Aldo-Keto reductase family 1 member B10 expression.
Chen D; Shen Z; Cheng X; Wang Q; Zhou J; Ren F; Sun Y; Wang H; Huang R
Bioengineered; 2021 Dec; 12(1):1964-1975. PubMed ID: 34027794
[TBL] [Abstract][Full Text] [Related]
8. Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma.
Lin L; Wu X; Jiang Y; Deng C; Luo X; Han J; Hu J; Cao X
PeerJ; 2022; 10():e13402. PubMed ID: 35646490
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
[No Abstract] [Full Text] [Related]
10. RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway.
Zhang D; Jiang Q; Ge X; Shi Y; Ye T; Mi Y; Xie T; Li Q; Ye Q
Int J Biol Sci; 2021; 17(10):2622-2632. PubMed ID: 34326698
[TBL] [Abstract][Full Text] [Related]
11. STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway.
Xu H; Yang X; Xuan X; Wu D; Zhang J; Xu X; Zhao Y; Ma C; Li D
Neoplasia; 2021 Jun; 23(6):607-623. PubMed ID: 34102455
[TBL] [Abstract][Full Text] [Related]
12. Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells.
Ma J; Yan R; Zu X; Cheng JM; Rao K; Liao DF; Cao D
J Biol Chem; 2008 Feb; 283(6):3418-3423. PubMed ID: 18056116
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
[TBL] [Abstract][Full Text] [Related]
14. GRIN2D knockdown suppresses the progression of lung adenocarcinoma by regulating the E2F signalling pathway.
Chen Z; Song Y; Li P; Gao W
Cell Signal; 2023 Jul; 107():110685. PubMed ID: 37084840
[TBL] [Abstract][Full Text] [Related]
15. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma.
Ma G; Yang L; Dong J; Zhang L
Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009
[TBL] [Abstract][Full Text] [Related]
16. Flotilin-1 promotes the tumorigenicity and progression of malignant phenotype in human lung adenocarcinoma.
Guo AY; Liang XJ; Liu RJ; Li XX; Bi W; Zhou LY; Tang CE; Yan A; Chen ZC; Zhang PF
Cancer Biol Ther; 2017 Sep; 18(9):715-722. PubMed ID: 28825855
[TBL] [Abstract][Full Text] [Related]
17. TRIM36 enhances lung adenocarcinoma radiosensitivity and inhibits tumorigenesis through promoting RAD51 ubiquitination and antagonizing hsa-miR-376a-5p.
Yu S; Li W; Liu X; Zhang H; Liu X; Zhang LW
Biochem Biophys Res Commun; 2022 Nov; 628():1-10. PubMed ID: 36058131
[TBL] [Abstract][Full Text] [Related]
18. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.
Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X
J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964
[TBL] [Abstract][Full Text] [Related]
19. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of AKR1B10 in patients with resected lung adenocarcinoma.
Hung JJ; Yeh YC; Hsu WH
Thorac Cancer; 2018 Nov; 9(11):1492-1499. PubMed ID: 30253058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
